A new blood test for diagnosing Alzheimer's Disease
Whole blood filter paper assay for Alzheimers Disease
This study is working on a simple blood test that could help doctors diagnose Alzheimer's Disease and other types of dementia earlier and more accurately, making it easier for people who are having memory issues to get the answers they need.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Biospyder Technologies, INC. NIH-funded |
| Lab location | 1 site (Carlsbad, United States) |
| Project ID | NIH-11128974 on NIH RePORTER |
What this research studies
This research focuses on developing a blood test that can help diagnose Alzheimer's Disease and potentially other forms of dementia. The test uses a small sample of blood collected via a finger-stick, which is then placed on filter paper and analyzed using advanced gene expression technology. The goal is to create a reliable diagnostic tool that can identify Alzheimer's with high accuracy, addressing a significant need for early and definitive diagnosis. This approach aims to reduce the uncertainty and delay in diagnosing patients who may be experiencing mild cognitive impairment.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals experiencing mild cognitive impairment or those at risk for Alzheimer's Disease.
Not a fit: Patients with established Alzheimer's Disease who are already receiving treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a quick and accurate method for diagnosing Alzheimer's Disease, allowing for earlier intervention and better patient management.
How similar studies have performed: Previous research has shown promising results with similar blood-based diagnostic approaches for Alzheimer's Disease, indicating potential for success in this area.
Where this research is happening
Carlsbad, United States
- Biospyder Technologies, INC. — Carlsbad, United States (Active)
Researchers
- Principal investigator: Seligmann, Bruce E. — Biospyder Technologies, INC.
- Study coordinator: Seligmann, Bruce E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.